This new PeDRA webinar dives into the latest advancements in TYK2 (Tyrosine Kinase 2) research, examining its potential role in the treatment of various pediatric dermatological conditions. Expert, Johann Gudjonsson, MD, PhD discusses the emerging therapeutic strategies targeting TYK2, their clinical applications, and the future direction of pediatric dermatology treatments. Kelly Cordoro, MD moderates this excellent program. View the video presentation here .
